Colon cancer itself rarely drives the number on the scale upward in the way many people assume. The weight gain that patients and survivors notice is almost always a consequence of treatment, medications, shifts in body composition, or behavioral changes triggered by the diagnosis and its aftermath. In some cases, fluid accumulation from advanced disease creates the appearance of gaining weight even when muscle and nutritional status are declining. The relationship between colon cancer and weight gain is real, but it runs through several indirect pathways that are worth understanding separately.
Chemotherapy and the Medications That Come With It
The most common culprit behind weight gain during colon cancer treatment is not the tumor but the drugs used to fight it. Adjuvant chemotherapy for colon cancer typically spans several months, and during that time patients frequently put on weight. A clinical trial tracking over 2,400 colon cancer patients found that roughly a quarter gained more than five kilograms during adjuvant chemotherapy, while fewer than one in ten lost that much.1Nature. Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial Even in a smaller pilot study of patients who walked daily during treatment, participants still gained about one to one-and-a-half kilograms on average.2PubMed Central. A randomized pilot study with daily walking during adjuvant chemotherapy for patients with breast and colorectal cancer
A significant contributor is dexamethasone, a corticosteroid routinely given before and after chemotherapy infusions to prevent nausea. Corticosteroids are well known for increasing appetite and promoting fat storage, and dexamethasone is no exception. In one study of patients receiving it for anti-nausea prophylaxis, about one in six reported weight gain, and nearly one in five reported noticeably increased appetite in just the week following treatment.3PubMed Central. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy That cycle repeats with every round of chemo, so the cumulative effect over months of treatment can be substantial. Patients sometimes feel confused: they expected to lose weight during cancer treatment, and instead the opposite happens. But the steroid-driven appetite increase, combined with fatigue that limits movement, creates conditions where gaining weight is almost the default.
Sarcopenic Obesity and the Illusion of Stability
One of the more insidious forms of weight change during colon cancer is sarcopenic obesity, a condition where muscle mass drops while fat mass increases. The scale might barely move, or it might tick upward, but the underlying shift in body composition is significant and often invisible without imaging. Cancer patients who are already overweight are especially vulnerable because severe muscle depletion is easiest to miss in obese individuals. Specialized analysis of CT scans taken during routine cancer monitoring can reveal this hidden muscle wasting even when outward weight seems unchanged.4PubMed. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy
Older patients face a double hit here. Aging on its own tends to reduce muscle and increase fat, and cancer treatment accelerates that process.5Arq Gastroenterol. Muscle depleted obesity in individuals screened for colorectal cancer A patient might come through treatment at a similar weight but in a fundamentally different physical state: weaker, carrying more fat around the midsection, and with less lean tissue to support daily functioning. This matters because muscle mass affects how well the body tolerates further treatment, handles recovery from surgery, and maintains metabolic health. When patients or their families notice clothes fitting differently or a thickening around the waist despite not eating more than usual, sarcopenic obesity is often the explanation.
Fluid Retention and Ascites
In more advanced colon cancer, weight gain can come not from fat or muscle shifts but from fluid. Ascites is the buildup of fluid in the abdominal cavity, and it produces noticeable abdominal swelling along with a measurable jump on the scale. Symptoms typically include abdominal distension, nausea, early satiety, shortness of breath, swelling in the legs, and weight gain.6PubMed Central. Management of ascites due to gastrointestinal malignancy The fluid accumulates because tumors can spread across the peritoneal lining, block lymphatic drainage, or cause pressure changes in the portal vein system.
This form of weight gain is qualitatively different from the gradual fat gain seen during chemotherapy. It tends to come on faster, produces a distinct tightness and bloating in the abdomen, and is sometimes the symptom that first brings someone with undiagnosed advanced cancer to a doctor. The weight gain from ascites does not respond to dietary changes or exercise because it is not related to calorie balance. Treatment involves draining the fluid directly (a procedure called paracentesis) or addressing the underlying cause. If you or someone you know experiences rapid abdominal swelling alongside other symptoms of advanced cancer, fluid buildup should be on the radar as a possible explanation.
Hormonal Disruptions and Metabolic Signaling
Cancer reshapes the body’s hormonal landscape in ways that can promote weight gain even before treatment starts. Colon tumors, like many cancers, trigger chronic low-grade inflammation that interferes with normal metabolic signaling. Research on gastrointestinal cancer patients has shown that inflammatory markers like interleukin-6 and tumor necrosis factor-alpha climb as the disease progresses. At the same time, ghrelin, one of the hormones that normally regulates hunger, becomes dysregulated. Ghrelin levels rise alongside inflammation, yet instead of producing the expected appetite-stimulating effect in a coordinated way, the body enters a state of ghrelin resistance where energy regulation goes haywire.7PubMed Central. Inflammatory cytokines, appetite-regulating hormones, and energy metabolism in patients with gastrointestinal cancer
Separately, the link between obesity and colon cancer runs partly through insulin and insulin-like growth factors. Abdominal fat promotes insulin resistance, which in turn raises circulating insulin levels and alters the activity of sex steroids and adipocyte-derived hormones like leptin and adiponectin.8The American Journal of Clinical Nutrition. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies For patients who were already carrying excess weight before their diagnosis, these metabolic disruptions feed into a cycle: the cancer worsens insulin resistance, the insulin resistance promotes fat storage, and the excess fat tissue produces more of the inflammatory signals that the tumor thrives in. Disruptions in the gut microbiome compound this further, as obesity-related shifts in gut bacteria can impair the intestinal barrier, alter how the body harvests energy from food, and sustain the chronic inflammatory state that supports tumor growth.9PubMed Central. Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Reduced Activity, Stress, and Changed Eating Patterns
A cancer diagnosis upends daily routines in ways that almost inevitably shift the energy balance toward weight gain. Fatigue from chemotherapy is one of the most commonly reported side effects, and it makes regular physical activity feel impossible for many patients. The stress of diagnosis and treatment also disrupts established health behaviors. Some patients turn to comfort eating; others find that the structure of their day collapses as treatment schedules dominate their calendar. Research on health behaviors during and after a cancer diagnosis has identified decreased physical activity and poor nutrition as direct contributors to weight gain, which in turn raises the risk of secondary problems like cardiovascular disease and diabetes.10Wiley Online Library / Cancer. Health behaviors during and after a cancer diagnosis
There is also a psychological dimension that gets underappreciated. Many patients describe feeling that their body is no longer under their control. The combined effect of steroid-driven hunger, nausea that comes and goes unpredictably, food aversions or cravings created by treatment, and the emotional weight of the diagnosis itself creates a situation where maintaining pre-diagnosis eating patterns is genuinely hard. The weight gain is not a failure of willpower. It is the predictable result of a body under metabolic and psychological siege from multiple directions at once.
Who Gains the Most Weight During Treatment
Not everyone gains weight equally during colon cancer treatment, and the patterns are worth knowing. Data from the AVANT trial, a large study of patients receiving adjuvant chemotherapy for stage III colon cancer, showed some clear demographic splits. Men were more likely than women to gain more than five kilograms during treatment. Asian patients gained more weight and lost less compared to White patients.1Nature. Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial These differences likely reflect a mix of metabolic, dietary, and possibly pharmacokinetic factors, though the exact mechanisms are not fully sorted out.
Patients who are already overweight or obese before diagnosis tend to face a steeper climb. Their baseline metabolic profile, with higher insulin resistance and more visceral fat, sets up conditions where any additional metabolic insult from treatment amplifies fat storage. This group is also more prone to the sarcopenic obesity described earlier, because they may already have less muscle mass relative to their weight than leaner patients, and treatment accelerates the imbalance.
Does Post-Treatment Weight Gain Affect Outcomes
Patients who notice the scale creeping upward naturally worry about whether the weight gain affects their prognosis. The evidence here is more reassuring than you might expect, at least when it comes to cancer recurrence. A large analysis of stage III colon cancer patients found that neither baseline body mass index nor weight change during and after adjuvant therapy significantly affected cancer recurrence or death.11PubMed Central. Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803 A separate study of stage III patients found that even those who gained ten percent or more of their baseline weight did not have significantly worse recurrence-free survival compared to those who gained less.12PubMed. Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes
Interestingly, weight loss after treatment appears to be a much stronger warning signal than weight gain. In a study of Kaiser Permanente patients who had completed treatment for stage I through III colorectal cancer, losing at least ten percent of baseline weight was associated with roughly three times the risk of dying from colorectal cancer specifically, and a similar increase in overall mortality. For every five percent of baseline weight lost, colorectal cancer death risk rose by about forty percent. Weight gain, by contrast, showed no significant association with either cancer-specific or overall death.13AACR Journals (Cancer Epidemiology, Biomarkers & Prevention). Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population The implication is counterintuitive for patients who feel distressed about gaining weight: in the survivorship period, maintaining or even gaining weight tends to signal a body that is recovering and sustaining itself, while significant weight loss can indicate disease progression or nutritional failure.
This does not mean unlimited weight gain is harmless. Excess body fat raises risks for cardiovascular disease, diabetes, and other long-term health problems that matter independently of cancer prognosis. But the specific fear that treatment-related weight gain will cause the cancer to come back faster does not appear to be supported by the available data for stage III colon cancer.
When Weight Gain Happens Before Diagnosis
It is worth separating two questions that often get tangled together: whether colon cancer causes weight gain, and whether weight gain raises colon cancer risk. Most of the scientific literature runs in the second direction. A large meta-analysis of prospective studies found that obesity is a clear risk factor for developing colon cancer, particularly in men, with abdominal obesity carrying the strongest association.8The American Journal of Clinical Nutrition. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies The mechanisms linking excess weight to cancer development involve insulin resistance, elevated insulin-like growth factors, and chronic inflammation driven by visceral fat tissue.
So when someone gains weight and is later diagnosed with colon cancer, the weight gain usually preceded and possibly contributed to the cancer rather than the other way around. The tumor itself, in its early stages, is unlikely to cause noticeable weight gain. It is only during treatment, or in advanced disease with complications like ascites, that colon cancer becomes a meaningful driver of weight change. For people searching for an explanation after a diagnosis, this distinction matters: the weight you gained before diagnosis was likely part of the risk profile, not a symptom you missed.
The Gut Microbiome Connection
One area of growing research interest is how the gut microbiome fits into the relationship between obesity and colon cancer. The colon is, after all, the organ most intimately intertwined with the trillions of bacteria that live in the digestive tract. Obesity shifts the composition of gut bacteria in ways that impair the intestinal lining, alter how the body extracts and stores energy from food, and sustain a state of chronic low-grade inflammation. These microbiome-driven changes may promote the development of colorectal tumors through several overlapping pathways, including metabolic dysregulation and weakened gut barrier function.9PubMed Central. Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
What makes this relevant to weight gain during and after treatment is that chemotherapy and antibiotics (commonly prescribed around surgery) further disrupt the microbiome. A gut bacterial community that was already shifted by obesity gets hit again by treatment, potentially making it even harder for the body to regulate energy balance and inflammation in recovery. Research in this area is still building, and no one has yet shown that a specific probiotic or dietary intervention can reliably prevent treatment-related weight gain. But the microbiome is increasingly recognized as a mediating factor that helps explain why colon cancer patients, more than patients with many other cancers, experience such pronounced metabolic disruption during the course of their disease and its treatment.
Immunotherapy and Emerging Endocrine Side Effects
As colon cancer treatment evolves, newer therapies are introducing weight-related complications that earlier generations of patients did not face. Immune checkpoint inhibitors, now used for certain types of advanced or microsatellite-instability-high colorectal cancers, can trigger endocrine side effects including thyroid dysfunction. Hypothyroidism, or an underactive thyroid, is one of the more common endocrine toxicities of these drugs, and it directly promotes weight gain by slowing metabolism. Unlike the appetite-driven weight gain from corticosteroids, thyroid-related weight gain happens even when eating habits have not changed, which can be especially confusing for patients. When caught, thyroid dysfunction is treatable with replacement hormone, but it needs to be monitored because the onset can be gradual and the symptoms (fatigue, cold intolerance, weight gain) overlap with what many patients already attribute to their cancer or chemotherapy.
The landscape of colon cancer treatment is shifting fast enough that the weight-related side effect profile a patient experiences today may look quite different from what was standard a decade ago. Patients starting on newer regimens should ask their oncology team specifically about metabolic and endocrine monitoring so that treatable causes of weight gain do not go unrecognized.